Paper2467383
HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy.
Larder BA and 2 others. Science, 1989. Cited by 1,486 papers, by iCite.
Cite this record
ConductScience Library. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Papers, record 2467383. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2467383
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Comparative Study, Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acquired Immunodeficiency Syndrome | Major topic |
| HIV | Major topic |
| Zidovudine | Major topic |
| AIDS-Related Complex | |
| Dideoxynucleosides | |
| Drug Resistance | |
| Foscarnet | |
| HIV Core Protein p24 | |
| HeLa Cells | |
| Humans | |
| Microbial Sensitivity Tests | |
| Phosphonoacetic Acid | |
| Retroviridae Proteins | |
| Reverse Transcriptase Inhibitors | |
| Viral Plaque Assay | |
| Virus Replication | |
| Zalcitabine |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| AI-52578 | NIAID NIH HHS | United States | N01AI052578 | PubMed and NIH | NIH RePORTER |
| AI-62548 | NIAID NIH HHS | United States | N01AI062548 | PubMed and NIH | NIH RePORTER |
| HB-67019 | NHLBI NIH HHS | United States | N01HB067019 | PubMed and NIH | NIH RePORTER |
Cited by389
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,486 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41980093 | Recurrent mutations drive rapid HIV escape from two broadly neutralizing antibodies in vivo. | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/41980093 | PubMed |
| 40573433 | Consensus Sequences for Gag and Pol Introduced into HIV-1 Clade B Laboratory Strains Differentially Influence the Impact of Point Mutations Associated with Immune Escape and with Drug Resistance on Viral Replicative Capacity. | Viruses | 2025 | https://conductscience.org/library/papers/40573433 | PubMed |
| 40416942 | Antimicrobial resistance with a focus on antibacterial, antifungal, antimalarial, and antiviral drugs resistance, its threat, global priority pathogens, prevention, and control strategies: a review. | Ther Adv Infect Dis | 2025 | https://conductscience.org/library/papers/40416942 | PubMed |
| 40257980 | Addressing data management and analysis challenges in viral genomics: The Swiss HIV cohort study viral next generation sequencing database. | PLOS Digit Health | 2025 | https://conductscience.org/library/papers/40257980 | PubMed |
| 39613191 | Efficacy assessment of antiretroviral drugs against equine infectious anemia virus in vitro. | Virus Res | 2024 | https://conductscience.org/library/papers/39613191 | PubMed |
| 38898037 | Broad-spectrum activity against mosquito-borne flaviviruses achieved by a targeted protein degradation mechanism. | Nat Commun | 2024 | https://conductscience.org/library/papers/38898037 | PubMed |
| 37940003 | HIV-1 Nef Changes the Proteome of T Cells Extracellular Vesicles Depleting IFITMs and Other Antiviral Factors. | Mol Cell Proteomics | 2023 | https://conductscience.org/library/papers/37940003 | PubMed |
| 37851634 | Need assessment for HIV drug resistance testing and landscape of current and future technologies in low- and middle-income countries. | PLOS Glob Public Health | 2023 | https://conductscience.org/library/papers/37851634 | PubMed |
| 36992421 | Cellular Targets of HIV-1 Protease: Just the Tip of the Iceberg? | Viruses | 2023 | https://conductscience.org/library/papers/36992421 | PubMed |
| 36973419 | Monocyte-derived macrophages contain persistent latent HIV reservoirs. | Nat Microbiol | 2023 | https://conductscience.org/library/papers/36973419 | PubMed |
| 36296633 | Anti-HIV Ermiasolides from Croton megalocarpus. | Molecules | 2022 | https://conductscience.org/library/papers/36296633 | PubMed |
| 36145398 | Current Research on HIV Drug Resistance-A Topical Collection with "Pathogens". | Pathogens | 2022 | https://conductscience.org/library/papers/36145398 | PubMed |
| 36130204 | New antiretroviral inhibitors and HIV-1 drug resistance: more focus on 90% HIV-1 isolates? | FEMS Microbiol Rev | 2023 | https://conductscience.org/library/papers/36130204 | PubMed |
| 35446679 | Wonder of wonders, miracle of miracles: the unprecedented speed of COVID-19 science. | Physiol Rev | 2022 | https://conductscience.org/library/papers/35446679 | PubMed |
| 35291198 | AIDS at 40th: The progress of HIV treatment in Japan. | Glob Health Med | 2022 | https://conductscience.org/library/papers/35291198 | PubMed |
| 34578337 | Identification of Potential Drug Targets of Broad-Spectrum Inhibitors with a Michael Acceptor Moiety Using Shotgun Proteomics. | Viruses | 2021 | https://conductscience.org/library/papers/34578337 | PubMed |
| 34473060 | Understanding patterns of HIV multi-drug resistance through models of temporal and spatial drug heterogeneity. | Elife | 2021 | https://conductscience.org/library/papers/34473060 | PubMed |
| 33444376 | The clarifying role of time series data in the population genetics of HIV. | PLoS Genet | 2021 | https://conductscience.org/library/papers/33444376 | PubMed |
| 33364074 | A 35-Year Review of Pre-Clinical HIV Therapeutics Research Reported by NIH ChemDB: Influences of Target Discoveries, Drug Approvals and Research Funding. | J AIDS Clin Res | 2020 | https://conductscience.org/library/papers/33364074 | PubMed |
| 32362789 | The road to new antiviral therapies. | Clin Appl Immunol Rev | 2005 | https://conductscience.org/library/papers/32362789 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| TMED2 | 10959 | PubTator's text mining | https://conductscience.org/library/genes/10959 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2467383
GET https://conductscience.org/api/papers/v1/2467383/cited_by?page=2